Confidentiality vs. Transparency: Germany’s Drug Price Dilemma Unpacked

Are confidential drug prices coming to Germany? Until now, the reimbursed prices of drugs are in the public domain (Lauer Taxe), but the MFG proposes to allow confidential prices.

I have recently discussed the proposed introduction of confidential reimbursement prices in a webinar hosted by Phraktion.

Since the webinar, the Federal Council has rejected the proposal. However, the German Ministry of Health still maintains its position and presses ahead with the proposed law changes. The final decision is still outstanding.

Want my free guide about German HTA?

X